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XenobioticsGST family genes have a critical role in xenobiotic metabolism and drug resistance. Among the GST family the
GST-μ, GST-π, GST-α and GST-θ are the most abundant classes and have a major role in the carcinogen detoxiﬁ-
cation process. Nevertheless the activity of these enzymes may differ due to polymorphisms which ultimately
results in interindividual susceptibility to cancer development. In this work, we have analyzed the potentially
deleterious nsSNPs that can alter the function of these genes. As a result among the nsSNPs, 101 (42.61%) were
found to be deleterious by a sequence homology-based tool, 67 (28.27%) by a structure homology based tool
and a total of 59 (24.89%) by both. We propose a modeled structure of the ﬁve highly deleterious mutant
proteins. Our results will provide useful information in selecting target SNPs that are likely to have an impact
on GST activity and contribute to an individual's susceptibility to the disease.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Genetic variation in the human genome is an emerging resource for
studying cancer and other diseases. Single-nucleotide polymorphisms
(SNPs) are themost common type of DNA sequence variation, account-
ing for approximately 90% of the DNA polymorphism in humans [1] and
some of these have been found to be associated with some rare human
diseases. As per NCBI dbSNP Build 138 statistics approx 62.67 million
human SNPs have been submitted; out of that, 44.27 million SNPs are
validated. Common SNPs are found, on average, every 100–300 base
pairs in the 3-billion-base pair genome [2], although their density varies
between regions. A non-synonymous single nucleotide polymorphism
(nsSNP), which is present within the exon of a gene, is responsible for
the incorporation of an alternative amino acid and known to be one of
the main causes for major genetic disorders. However, tolerant nsSNPs
are not deleterious and are not involved in any genetic disorders,
whereas deleterious nsSNPs have a profound inﬂuence on protein struc-
ture and its interaction. Therefore, it is important to differentiate delete-
rious nsSNPs from tolerant nsSNPs to characterize the genetic basis of
human diseases. Discovering such deleterious nsSNPs is the main task
of Pharmacogenomics. However, which set of SNPs to be screened is
an important issue to understand betweenman and diseases. A possiblebhattacharjee@nehu.ac.in
. This is an open access article underway to overcome this problemwould be to prioritize SNPs according to
their functional signiﬁcance [3,4] by using Bioinformatics prediction
tools, which may help to discriminate neutral SNPs from SNPs of likely
functional importance and could also be useful to reveal the structural
basis of disease mutations.
Glutathione transferase (GST), a class of phase II xenobiotic metabo-
lism enzymes (EC 2.5.1.18) has received a great deal of attention owing
to their importance in cellular detoxiﬁcation. In fact GST, catalyzes the
conjugation of toxic substrates, with glutathione (GSH) and decreases
their toxic activity against cellular macromolecules (prevent adduct
formation, and thus protect organisms from DNA damage or protecting
chromosomes from oxidative damage) [5]. In addition to phase II metab-
olism, GSTs are also involved in stress response, oncogenesis, tumor pro-
gression, drug resistance, biosynthesis andmetabolism of prostaglandins,
steroids, and leukotrienes [6]. More recently, GST isoenzymes have also
been found tomodulate cell signaling pathways that control cell prolifer-
ation and cell death [6,7]. In the GSTP−/−knockout mouse model,
the rapid development of 12-O-tetradecanoylphorbol-13-acetate (TPA)
induced cutaneous papilloma was observed than wild-type mice, which
provides evidence that the enzyme is a key determinant of the proinﬂam-
matory tumor environment [8]. The human cytosolic GST consists of GST-
α (alpha), GST-μ (mu), GST-π (pi), GST-σ (sigma), GST-ω (omega), GST-θ
(theta), and GST-ξ (zeta) based on their sequence similarities, substrate
speciﬁcity, and immune-reactivity. Among these classes GST-μ, GST-π,
GST-α and GST-θ are the most abundant and variation in GST alleles is
very common in the population. This variation makes signiﬁcant contri-
bution to inter-individual differences in the metabolism of xenobioticthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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quence of these GSTs are reported, whichmay affect the enzymatic activ-
ity and subsequently exert deleterious effects [9]. Many studies
demonstrated that the polymorphisms of these GSTs are associated
with different types of cancer [10,11]. However many studies did not
show consistency which could be due to the overlapping substrate afﬁn-
ity of these enzymes or that these SNPs might not have an impact on en-
zyme structure and function. Therefore it is important to identify
deleterious nsSNPs which have an impact on the structure and function
of carcinogen detoxiﬁcation genes. In the GST family, GST-μ, GST-π,
GST-α and GST-θ are major classes involve in carcinogen detoxiﬁcation
process and other carcinogenesis events. Therefore the present study
takes a computational approach for in silico investigation on nsSNPmuta-
tion on these GST genes. To identify and distinguish nsSNPmutation that
has a functional impact on protein structure through an experimental ap-
proach is time and money consuming. Thus the computational approach
can help one to select SNPs for genotyping in molecular studies by using
algorithms based on the evolutionary and biochemical severity of an
amino acid substitution approach.
We applied different freely available computational algorithms
based on sequence homology and physicochemical properties of the
amino acid residue and an in silico site directed mutagenesis tool in
this work to identify the possible deleterious mutations. We proposed
a modeled structure of mutant proteins and compared them with the
native protein. In general, these computational methods provide a
feasible, high throughputway to determine the impact of large numbers
of nsSNPs on protein function.
Methods and materials
Database mining for SNPs of GST family genes
We used National Center for Biotechnology Information (NCBI)
database dbSNP (http://www.ncbi.nlm.nih.gov/Projects/SNP) [12] for
our computational analysis.
Functional analysis of nsSNPs by sequence and structural homology based
method (SIFT and Polyphen)
Residue changes that have an impact on the biophysical and struc-
tural properties of protein are known to be pathogenic or deleterious
[13]. In our study we used two complementary Bioinformatics tools
for high throughput prediction of the potential function impact of the
nsSNPs of GST family genes: Sorting Intolerant from Tolerent (SIFT)
(http://block.fhcrc.org/sift/SIFT.html) and Polymorphism Phenotyping
(PolyPhen) (http://coot.embl.de/PolyPhen/). SIFT is a sequence based
homology tool which presumes that important amino acidswill be con-
served in protein family and so changes at well conserve protein tend toTable 1
List of human GST genes in α, μ, π and θ family and their SNP distribution.
Gene Name Total SNP nsSNP % nsSNP sSNP %sSNP
GSTM1 207 13 6.28 11 5.31
GSTM2 303 13 4.29 8 2.64
GSTM3 144 12 8.33 8 5.56
GSTM4 210 24 11.42 12 5.71
GSTM5 208 30 14.42 14 6.73
GSTA1 281 29 10.32 17 6.05
GSTA2 316 26 8.22 13 4.11
GSTA3 291 18 6.19 8 2.75
GSTA4 432 9 2.08 4 0.93
GSTA5 382 16 4.19 1 0.26
GSTP1 180 17 9.44 6 3.33
GSTT1 87 18 20.69 9 10.34
GSTT2 152 12 7.89 2 1.32
Total 3193 237 7.42 113 3.54
nsSNP: non synonymous SNP; sSNP: synonymous SNP; 3′UTR: 3′ Untranslated region; 5′UTR:be predicted as deleterious [14]. The algorithm used a modiﬁed version
of PSI-BLAST [15] and Dirichlet mixture regularization [16] to construct
a multiple sequence alignment of protein that can be globally aligned to
the query sequence and belong to the same clade. SIFT is a multistep
procedure that, given a protein sequence: (a) searches for similar
sequence; (b) chooses closely related sequences that may share similar
function; (c) obtains the multiple alignment of chosen sequence; and
(d) calculates the normalized probability for all possible substitutions
at each position with normalized alignment. Substitution at each
position from the normalize probability less than a chosen cutoff are
predicted to be tolerated. SIFT scores are designated as tolerant
(0.201–1.00), borderline (0.101–0.20), potentially intolerant (0.051–
0.10), or intolerant (0.00–0.05) [16]. Therefore an SNP is termed as
deleterious if the cutoff value in SIFT program has a tolerance index of
≤0.05. The value higher the tolerance index, the less functional impact
a particular amino acid substitution is likely to have.
PolyPhen is a structural-homology-based tool that predicts the
impact of an amino acid substitution on the structure and function
of a human protein. Predictions are based on a combination of
phylogenetic, structural and sequence annotation information charac-
terizing a substitution and its position in the protein. For a given
amino acid variation, PolyPhen performs several steps: (a) extraction
of sequence-based features of the substitution site from the UniProt
database; (b) calculation of proﬁle scores for two amino acid variants;
and (c) calculation of structural parameters and contacts of a substitut-
ed residue. It calculates the PSIC score for each of two variants and then
computes the PSIC score difference between them. The higher the PSIC
score difference is, the higher is the functional impact a particular amino
acid likely to have and on the basis of these score polymorphisms can be
classiﬁed as probably benign (0.000–0.999), borderline (1.000–1.249),
potentially damaging (1.250–1.499), possibly damaging (1.500–1.999),
or damaging (≥2.000) [17].
Modeling nsSNP locations on protein structure and their RMSD difference
Structural analysis was performed for evaluating the structural sta-
bility of native and mutant protein. A graphical program for computa-
tional aided protein engineering, TRITON has been used for modeling
mutant protein [18]. TRITON uses the external program MODELLER to
construct structures ofmutant protein based on thewild-type structure
by homology modeling method. Energy minimization for 3D structures
was performed using NOMAD-Ref server [19]. This server uses Gromacs
as a default force ﬁeld for energyminimization based on themethods of
steepest descent, conjugate gradient and L-BFGSmethods [20]. A conju-
gate gradient method was used for optimizing the 3D structures. The
deviation between the two structures was evaluated by their root
mean square deviation (RMSD) values. RMSD values more than 0.15
were considered as signiﬁcant structural perturbations that could have3′ UTR %3′ UTR 5′ UTR %5′ UTR iSNP % iSNP
7 3.38 0 0 176 85.02
7 2.31 0 0 275 90.76
33 22.92 6 4.17 85 59.03
4 1.9 1 0.48 169 80.48
4 1.92 1 0.48 159 76.44
16 5.69 9 3.2 210 74.73
6 1.9 2 0.63 269 85.13
2 0.69 5 1.72 258 88.66
9 2.08 3 0.69 407 94.21
1 0.26 2 0.52 362 94.76
3 1.67 6 3.33 148 82.22
1 1.15 5 5.75 54 62.07
2 1.32 0 0 138 90.79
95 2.98 40 1.25 2710 84.87
5′ Untranslated region; and iSNP: intronic SNP.
Table 2
List of nsSNPs that were predicted to be deleterious.
SNP ID Gene name Nucleotide change Amino acid substitution Tolerance index PSIC ID Validation
rs72549312 GSTM1 C–T P179L 0.11 1.933 No
rs72549313 GSTM1 C–T R187C 0.00 1.000 No
rs184653774 GSTM1 A–C D9E 0.02 1.745 Yes
rs147668562 GSTM1 A–G N85S 0.10 1.561 Yes
rs142484086 GSTM1 C–T R145W 0.02 2.390 Yes
rs11540636 GSTM2 C–T F148S 0.00 1.715 Yes
rs140199111 GSTM2 G–T G12W 0.00 2.785 No
rs145910843 GSTM2 A–G R18H 0.00 1.484 No
rs147235683 GSTM2 A–G R78Q 0.00 2.225 No
rs146447815 GSTM2 A–G D106G 0.00 2.034 No
rs143184866 GSTM2 A–G G143E 0.00 1.281 No
rs141100983 GSTM2 A–G Y161C 0.00 1.505 Yes
rs140675803 GSTM2 A–G R96H 0.00 0.921 Yes
rs11546855 GSTM2 A–G D42G 0.01 2.294 No
rs1803686 GSTM3 C–A R191L 0.00 3.001 No
rs1803687 GSTM3 G–C K128N 0.00 2.331 Yes
rs11555177 GSTM3 T–C S48G 0.05 1.370 No
rs184721419 GSTM3 C–T R172H 0.04 0.584 Yes
rs138797459 GSTM3 C–T S121G 0.04 1.123 No
rs146952826 GSTM3 C–T R86H 0.05 0.751 Yes
rs150988571 GSTM3 C–T E33K 0.03 0.880 Yes
rs140815169 GSTM3 A–G L23P 0.00 2.365 Yes
rs142070930 GSTM3 C–T G10R 0.00 2.293 No
rs3211195 GSTM4 A–G M135I 0.02 0.752 Yes
rs145606771 GSTM4 A–G R11H 0.00 1.332 No
rs148886417 GSTM4 C–G I17M 0.00 2.144 Yes
rs138088784 GSTM4 G–T R18L 0.00 3.158 Yes
rs145858198 GSTM4 C–T C78R 1.00 0.647 Yes
rs139656805 GSTM4 A–G E91K 0.02 1.071 No
rs144284999 GSTM4 A–G R96H 0.00 0.925 Yes
rs142265412 GSTM4 C–G A104G 0.01 1.005 Yes
rs114328674 GSTM4 A–G R168C 0.00 2.519 Yes
rs61734547 GSTM5 G–T L13R 0.00 0.890 No
rs144877199 GSTM5 C–G A16G 0.02 1.374 No
rs145616779 GSTM5 A–G E22K 0.15 0.895 No
rs142533115 GSTM5 A–G V29M 0.00 1.234 No
rs139457478 GSTM5 C–T I76T 0.00 2.780 No
rs147739570 GSTM5 C–T R78C 0.03 0.990 Yes
rs148956224 GSTM5 A–G R96H 0.00 0.926 No
rs144915668 GSTM5 C–G N107K 0.09 0.696 Yes
rs144530836 GSTM5 A–T L114Q 0.00 1.750 Yes
rs140499099 GSTM5 C–T R145W 0.02 2.147 Yes
rs150881777 GSTM5 C–T W147R 0.00 3.864 Yes
rs150417585 GSTM5 C–T R187C 0.00 0.917 Yes
rs137869431 GSTM5 A–G R187H 0.03 1.000 Yes
rs144827167 GSTM5 G–T G190V 0.04 0.500 No
rs113130058 GSTM5 A–G S217G 0.02 0.163 Yes
rs2234953 GSTT1 G–A E173K 0.04 2.240 Yes
rs2266637 GSTT1 G–A V169I 0.04 0.722 Yes
rs17856199 GSTT1 T–G F45C 0.00 2.993 Yes
rs2266635 GSTT1 G–A A21T 0.00 0.998 Yes
rs185499198 GSTT1 A–G R240W 0.01 2.270 Yes
rs77300908 GSTT1 C–T E204K 0.00 0.147 Yes
rs112867476 GSTT1 C–T R197H 0.00 2.429 No
rs139881998 GSTT1 A–T H162L 0.03 2.480 Yes
rs150601402 GSTT1 A–G R112W 0.02 2.037 Yes
rs141759372 GSTT1 A–G W101R 0.00 4.138 Yes
rs149896285 GSTT1 A–G M1T 0.00 3.563 No
rs1126752 GSTT2 C–T S68L 0.05 0.778 No
rs146675046 GSTT2 A–G E147K 0.01 2.092 Yes
rs1804666 GSTP1 G–A G78E 0.03 1.794 No
rs4986949 GSTP1 G–T D147Y 0.01 2.439 Yes
rs71534294 GSTP1 G–C D158H 0.00 2.234 Yes
rs11553892 GSTP1 C–A L176M 0.05 1.417 Yes
rs45549733 GSTP1 C–T R187W 0.00 2.696 No
rs188653023 GSTP1 A–G R183H 0.01 1.198 Yes
rs191595383 GSTP1 C–G P197A 0.12 1.904 Yes
rs78507509 GSTP1 C–G P124A 0.13 1.918 Yes
rs1051983 GSTA1 G–T A216S 0.04 0.327 Yes
rs17414159 GSTA1 C–T C112R 0.53 2.081 No
rs73740645 GSTA1 A–T K64M 0.03 0.708 Yes
rs148795539 GSTA1 C–T E168K 0.00 1.938 No
rs1051778 GSTA1 A–T I128K 0.00 1.395 Yes
rs138688572 GSTA1 A–G I75T 0.00 1.529 Yes
rs140333826 GSTA1 A–G L72F 0.02 0.756 No
rs145721561 GSTA1 G–T A70D 0.00 2.332 ⁎
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Table 2 (continued)
SNP ID Gene name Nucleotide change Amino acid substitution Tolerance index PSIC ID Validation
rs61734623 GSTA1 A–T K64M 0.03 0.708 No
rs11552000 GSTA1 C–T M57T 0.01 2.011 No
rs138678278 GSTA1 A–C G48V 0.00 2.365 No
rs1803682 GSTA2 G–T K196N 0.03 1.202 Yes
rs2266631 GSTA2 C–T V149A 0.00 2.189 Yes
rs75013911 GSTA2 C–T E32K 0.00 2.044 Yes
rs151112301 GSTA2 A–G R131C 0.04 1.679 Yes
rs147776857 GSTA2 C–T G83R 0.00 2.520 Yes
rs138041732 GSTA2 A–C L180R 0.23 1.566 Yes
rs146304331 GSTA2 A–G R155W 0.20 1.183 Yes
rs142063997 GSTA2 C–T R20Q 0.00 2.382 Yes
rs139552194 GSTA2 G–T H8N 0.12 2.699 Yes
rs143619808 GSTA2 A–C K64N 0.01 0.586 No
rs61734623 GSTA2 A–T K64M 0.03 0.722 No
rs183168307 GSTA2 A–C M57I 0.06 1.560 Yes
rs11552000 GSTA2 C–T M57I 0.01 2.825 No
rs41273858 GSTA3 C–T N73D 0.10 1.974 Yes
rs1052661 GSTA3 A–C I71L 0.00 1.629 Yes
rs17851798 GSTA3 A–C M63I 0.04 2.057 Yes
rs59410661 GSTA3 A–G R13W 0.00 3.035 Yes
rs149910347 GSTA3 C–G S202T 0.01 1.281 Yes
rs143944137 GSTA3 A–G P200L 0.00 2.841 No
rs143163780 GSTA3 A–G T193M 0.00 1.840 Yes
rs144126679 GSTA3 A–C Y147D 0.00 3.028 Yes
rs141590731 GSTA3 C–T E97G 0.03 1.570 No
rs143379014 GSTA3 A–G F52L 0.00 2.732 No
rs148359991 GSTA3 C–G D47H 0.01 2.197 No
rs186026850 GSTA3 A–C E32D 0.00 0.503 Yes
rs141510758 GSTA3 C–T R20Q 0.00 2.494 No
rs45551133 GSTA4 C–T L100P 0.25 1.208 Yes
rs141595669 GSTA4 A–T F197I 0.00 2.569 No
rs139066992 GSTA4 C–T G144R 0.03 0.723 No
rs151284340 GSTA4 C–T K84R 0.01 0.890 Yes
rs140367015 GSTA5 A–T S142C 0.02 1.959 ⁎
rs145445113 GSTA5 A–C K141N 0.02 1.048 ⁎
rs146408369 GSTA5 C–T Y74C 0.00 3.242 Yes
rs185015376 GSTA5 C–T M1I 0.00 2.924 Yes
rs145528403 GSTA5 A–G T193M 0.00 0.530 Yes
rs150669459 GSTA5 C–T R20Q 0.00 2.349 No
⁎ SNPs were omitted from dbSNP database because its subsnp_id was deleted.
Table 3
RMSD and total energy of native and their respective mutant modeled structures 1TDI
R13W, 1TDI Y147D, 4GTU R18L, 3GTU R191L and 2C3NW101R.




R13W GSTA3 −27,029.410 −25,893.779 1.535
Y147D GSTA3 −27,029.410 −26,319.830 1.368
R18L GSTM4 −26,365.328 −25,996.713 0.924
R191L GSTM3 −57,996.078 −57,176.730 1.321
W101R GSTT1 −28,807.537 −28,944.705 0.937
69P. Yadav et al. / Genomics Data 2 (2014) 66–72functional implications for the protein [21]. Molecular graphics images
were produced using the UCSF Chimera package [22].
Result & discussion
SNP dataset
A total of 13 genes of four major classes of Cytosolic GST family viz.
GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTM1, GSTM2, GSTM3, GSTM4,
GSTM5, GSTP1, GSTT1 and GSTT2 investigated in this work were re-
trieved from the dbSNP database. These genes contained 3193 SNPs;
out of that 237 were found to be nsSNPs, and 113 to be coding synony-
mous SNPs (sSNPs). The noncoding SNPs consisted of 40 SNPs in the
5′ Untranslated region (UTR), 95 SNPs in the 3′ UTR region and 2708
intronic SNPs (iSNP). The number and percentage for every SNP type of
individual genes are given in Table 1. The coding nonsynonymous SNPs
were selected for our investigation.
Prediction of deleterious nsSNPs by SIFT and Polyphen Program
A sequence homology based tool, SIFT was used to determine the
conservation level of a particular single amino acid substitution in a pro-
tein based on the alignment of orthologous and/or paralogous protein
sequences. Among 237 nsSNPs, 101 nsSNPs (42.61%) were found to be
deleterious by a SIFT algorithm which showed a deleterious tolerance
index score between 0.00 and 0.05. Out of these deleterious nsSNPs,55 nsSNPs (52.88%) found to be exhibited highly deleterious tolerance
index score of 0.00 which could affect the protein function in these
genes.
Using Insilico tool Polyphen, 67 nsSNPs (28.27%) were found to be
deleterious having a PSIC score difference≥1.5. Out of which 19 nsSNPs
lie between a PSIC score difference ≥1.500 and ≥1.999 and were
predicted to be possibly deleterious. 40 nsSNPs lie between a PSIC
score difference ≥2.000 and≤2.999 and were predicted to be deleteri-
ous. 8 nsSNPs having a PSIC score difference ≥3.000 were predicted as
highly deleterious. It was also observed that 59 (24.89%) nsSNPs were
deleterious by SIFT as well as Polyphen tools. Deleterious nsSNPs pre-
dicted by SIFT and PolyPhen for GST genes are listed in Table 2.
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Highly deleterious nsSNPs having a tolerance index of 0.00 and a
PSIC score difference≥3.00 have been selected formodeling on their re-
spective native structure. A total of 8 nsSNPs fall in that criterion. Out of
these eight nsSNPs, two (rs146408369 of GSTA5 and rs150881777 of
GSTM5 genes) were excluded from modeling as the native protein
structure was not available. Further one more nsSNPs (rs149896285
of GSTT1 gene) was excluded as a single amino acid polymorphism
(SAP) occurred at the initiation codon. Therefore ﬁnally, a total of 5
nsSNPs (rs59410661, rs144126679 of GSTA3; rs1803686 of GSTM3;
rs138088784 of GSTM4 and rs141759372 of GSTT1 gene) has been
selected for modeling and analysis of the mutant structure. The
amino acid residue substitutions were performed by the TRITONFig. 1. Superimposed structure of native protein 1TDI (camel) with mutant protein 1TDI_R1
structure of native protein 1TDI (camel) with mutant protein 1TDI_Y147D (Carolina blue) shosoftware to get mutant modeled structures (1TDI_R13W, 1TDI_Y147D,
3GTU_R191L, 4GTU_R18L and 2C3N_W101R). Then energy minimiza-
tions were performed by the NOMAD-Ref server for native structure
and their respective mutant modeled structures. It was found that the
total energy of the mutant proteins 1TDI_R13W and 1TDI_Y147D were
−25893.779 and−26319.830 Kcal/mol, respectively and that of the na-
tive protein (1TDI) was −27029.410 Kcal/mol, for 3GTU and mutant
3GTU_R191L total energy was−57996.078 and−57176.730 Kcal/mol,
respectively; for 4GTU and mutant 4GTU_R18L, the total energy
was −26365.328 and −25996.713 Kcal/mol, respectively and for
2C3N and mutant 2C3N_W101R, the total energy was found to be
−28807.537 and−28944.705, respectively (Table 3). The RMSD values
for the modeled mutants were signiﬁcant for the pathogenicity for all
missense mutations. The RMSD value between the native type (1TDI)3W (Carolina blue) showing changes in secondary structure (a, b and c). Superimposed
wing changes in secondary structure (d, e and f).
71P. Yadav et al. / Genomics Data 2 (2014) 66–72and the mutant 1TDI_R13W and 1TDI_Y147D is 1.535 Å and 1.368 Å re-
spectively; between the native type (3GTU) and the mutant
3GTU_R191L is 1.321Å, between the native type (4GTU) and themutant
4GTU_R18L is 0.924 Å and between the native type (2C3N) and the mu-
tant 2C3N_W101R is 0.937 Å. The higher the RMSD value the more will
be the deviation between the native and mutant type structures, which
in turn changes their functional activity. Comparative structure analysis
of wild and mutant proteins revealed the occurrence of a secondary
structure and protein folding alteration due to SAP. Ser176, Asn177,
and Leu198 have mutated from a loop to helix and Gly14, Arg15, Met
16, and Ala25 from a helix to loop in mutant protein 1TDI_R13W dueFig. 2. Superimposed structure of native protein 4GTU (camel)withmutant protein 4GTU_R18L
of native protein 3GTU (camel) with mutant protein 3GTU_R191L (Carolina blue) showing ch
with mutant protein 2C3N_W101R (Carolina blue) showing changes in secondary structure (dto the SAP of arginine to tryptophan at position 13 (Fig. 1a, b & c). Like-
wise Ser142, His143, Ser176, Asn177, and Leu198 in mutant protein
1TDI_Y147D changed to a helix from loop and Gly14, Arg15, and
Met16 to a loop from helix as tyrosine changed to aspartic acid at posi-
tion 147 (Fig. 1d, e & f). In mutant 4GTU_R18L, Arg11 changed from a
loop to helix and Glu171, Pro172 from a helix to loop due to the SAP of
Arginine to leucine at position 18 (Fig. 2a, b). However one amino acid
of mutant 3GTU_R191L, Glu195 (Fig. 2c) and four amino acids of mutant
2C3N_W101R, Gln39, His40, Leu41, and Gln102 (Fig. 2d & e) changed
from a loop to helix due to the SAP of arginine to leucine at position
191 in 3GTU and tryptophan to arginine at position 101 in 2C3N,(Carolina blue) showing changes in secondary structure (a and b). Superimposed structure
anges in secondary structure (c). Superimposed structure of native protein 2C3N (camel)
and e).
72 P. Yadav et al. / Genomics Data 2 (2014) 66–72respectively. These structural changes of mutant proteins indicate that
there might be alterations in the binding afﬁnity of these proteins with
glutathione and other substrates which ultimately leads to aberrant car-
cinogens, drugs and xenobiotic metabolism.
Conclusions
Among all cytosolic GSTs,α, μ, π and θ classes aremainly found to be
involved in the carcinogen detoxiﬁcation process in addition to kinase
regulation and drug resistance [10,23]. However, the alteration of
enzymes present in these classes by polymorphism might explain
individual differences in susceptibility to cancer that exposed to the
same type of carcinogens and can be inﬂuenced the pharmacokinetics
of clinically-important drugs, but this is still limited to a small fraction
of nsSNPs identiﬁed. In our study, we investigated deleterious nsSNPs
which have functional inﬂuences on four major cytosolic classes of Glu-
tathione transferases through computational method. As a result four
genes were found to have ﬁve highly deleterious mutations viz. GSTA3
(R13Wand Y147D), GSTM4 (R18L), GSTM3 (R191L) andGSTT1(W101R)
with a PSIC difference score ≥3.00 and TI 0.00 and the mutant protein
structure showed alteration in their structure, energy and high RMSD,
which indicates their high divergence from one another. Finally we con-
clude that these ﬁve deleterious polymorphisms could be the prime tar-
get mutation for the altered detoxiﬁcation process of their respective
enzymes which ultimately leads to carcinogenesis event. Therefore our
analysis will provide useful information in selecting amino acid substitu-
tionswhich are supposed to increase susceptibility to certain diseases in-
cluding cancer by altering xenobiotic, carcinogens and drug metabolism
for further genotype–phenotype studies using molecular approaches.
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